Home/Publication/IDG & Shenzhen Capital to Advance Vaccine Development
IDG & Shenzhen Capital to Advance Vaccine Development 

03 Nov 2025

US$ 20.00

IDG Capital (IDG), Shenzhen Capital Group Co Ltd and Ruipu Pharma have invested over Rmb400 m (US$56.3 m) in the ......

Price / article: US$20.00
OR existing subscriber
Related Publications

KKR & Co Inc (KKR) has joined the ASX-listed non-bank lender Pepper Money Ltd to acquire the RAMS home loan portfolio...

Affirma Capital is leading an up to US$56 m investment in RMSI Ltd, a provider of engineering and geospatial solutions....

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.